Umbra Companies Financials
Financial Health Signals
Umbra Companies passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Umbra Companies generates $0.53 in operating cash flow (-$286K OCF vs -$544K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Umbra Companies earns $-12.3 in operating income for every $1 of interest expense (-$503K vs $41K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
This page shows Umbra Companies (UCIX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Umbra Companies generated $0 in revenue in fiscal year 2014.
Umbra Companies's EBITDA was -$391K in fiscal year 2014, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.9% from the prior year.
Umbra Companies generated -$286K in free cash flow in fiscal year 2014, representing cash available after capex. This represents an increase of 1.3% from the prior year.
Umbra Companies reported -$544K in net income in fiscal year 2014. This represents a decrease of 5225.0% from the prior year.
Umbra Companies held -$7K in cash against $198K in long-term debt as of fiscal year 2014.
Umbra Companies had 62M shares outstanding in fiscal year 2014. This represents an increase of 11.7% from the prior year.
Umbra Companies invested $0 in capex in fiscal year 2014, funding long-term assets and infrastructure. This represents a decrease of 100.0% from the prior year.
UCIX Income Statement
| Metric | Q1'15 | Q4'14 | Q3'14 | Q2'14 | Q1'14 | Q4'13 | Q3'13 | Q2'13 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $32K+104.3% | $16K-0.6% | $16K-86.6% | $118K+20.6% | $98K+11.8% | $87K+120.6% | $40K-22.5% | $51K |
| Operating Income | -$96K-20.5% | -$80K+0.1% | -$80K+56.1% | -$182K-12.4% | -$162K-1.4% | -$159K+10.4% | -$178K-95.2% | -$91K |
| Interest Expense | $3K+1.2% | $3K-72.4% | $12K-22.5% | $15K+30.0% | $11K+5490.1% | -$212-105.3% | $4K-78.0% | $18K |
| Income Tax | $0 | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Net Income | -$99K-19.8% | -$83K+9.2% | -$91K+53.5% | -$197K-13.6% | -$173K-8.7% | -$159K-145.4% | $351K+421.1% | -$109K |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
UCIX Balance Sheet
| Metric | Q1'15 | Q4'14 | Q3'14 | Q2'14 | Q1'14 | Q4'13 | Q3'13 | Q2'13 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.6M-1.7% | $1.6M-1.7% | $1.6M-1.7% | $1.7M-4.3% | $1.7M+0.9% | $1.7M-1.6% | $1.8M-1.8% | $1.8M |
| Current Assets | $0 | $0-100.0% | $368 | $0-100.0% | $31K+1195.4% | $2K-43.7% | $4K-49.5% | $9K |
| Cash & Equivalents | -$4K+44.5% | -$7K-2054.1% | $368 | $0-100.0% | $31K+1195.4% | $2K-43.7% | $4K-49.5% | $9K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $535K+14.8% | $466K+13.3% | $412K-62.7% | $1.1M+12.7% | $979K+24.0% | $789K+20.6% | $654K-36.7% | $1.0M |
| Current Liabilities | $520K+11.6% | $466K+33.4% | $350K+11.9% | $312K+103.1% | $154K-0.6% | $155K-24.2% | $204K-65.1% | $584K |
| Long-Term Debt | $15K-92.4% | $198K0.0% | $198K-74.9% | $791K-4.1% | $825K+30.0% | $634K+41.0% | $450K0.0% | $450K |
| Total Equity | $1.1M-8.4% | $1.2M-6.7% | $1.2M+116.5% | $570K-25.9% | $769K-18.4% | $942K-14.7% | $1.1M+46.0% | $757K |
| Retained Earnings | -$7.3M-1.4% | -$7.2M-1.2% | -$7.1M-1.3% | -$7.0M-2.9% | -$6.8M-2.6% | -$6.7M-2.5% | -$6.5M+5.1% | -$6.8M |
UCIX Cash Flow Statement
| Metric | Q1'15 | Q4'14 | Q3'14 | Q2'14 | Q1'14 | Q4'13 | Q3'13 | Q2'13 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$17K-114.8% | -$8K-156.1% | $14K+109.6% | -$146K-0.2% | -$146K+5.1% | -$154K-265.5% | -$42K-38.6% | -$30K |
| Capital Expenditures | $0 | $0 | $0+100.0% | -$15K-200.0% | $15K+538.0% | $2K | $0 | $0 |
| Free Cash Flow | -$17K-114.8% | -$8K-156.1% | $14K+108.7% | -$161K-0.2% | -$161K-3.1% | -$156K-271.1% | -$42K-38.6% | -$30K |
| Investing Cash Flow | $0 | $0 | $0-100.0% | $15K+200.0% | -$15K-538.0% | -$2K | $0 | $0 |
| Financing Cash Flow | $20K+162.1% | $8K+155.8% | -$14K-113.3% | $102K-46.4% | $190K+25.1% | $152K+274.6% | $41K+172.1% | -$56K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
UCIX Financial Ratios
| Metric | Q1'15 | Q4'14 | Q3'14 | Q2'14 | Q1'14 | Q4'13 | Q3'13 | Q2'13 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | 31.8% | N/A |
| Return on Assets | -6.3%-1.1pp | -5.1%+0.4pp | -5.5%+6.2pp | -11.8%-1.8pp | -9.9%-0.7pp | -9.2%-29.1pp | 19.9%+26.0pp | -6.1% |
| Current Ratio | 0.000.0 | 0.000.0 | 0.000.0 | 0.00-0.2 | 0.20+0.2 | 0.020.0 | 0.020.0 | 0.01 |
| Debt-to-Equity | 0.01-0.2 | 0.17+0.0 | 0.16-1.2 | 1.39+0.3 | 1.07+0.4 | 0.67+0.3 | 0.41-0.2 | 0.59 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Umbra Companies's annual revenue?
Umbra Companies (UCIX) reported $0 in total revenue for fiscal year 2014. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Umbra Companies profitable?
No, Umbra Companies (UCIX) reported a net income of -$544K in fiscal year 2014.
What is Umbra Companies's EBITDA?
Umbra Companies (UCIX) had EBITDA of -$391K in fiscal year 2014, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Umbra Companies have?
As of fiscal year 2014, Umbra Companies (UCIX) had -$7K in cash and equivalents against $198K in long-term debt.
What is Umbra Companies's free cash flow?
Umbra Companies (UCIX) generated -$286K in free cash flow during fiscal year 2014. This represents a 1.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Umbra Companies's operating cash flow?
Umbra Companies (UCIX) generated -$286K in operating cash flow during fiscal year 2014, representing cash generated from core business activities.
What are Umbra Companies's total assets?
Umbra Companies (UCIX) had $1.6M in total assets as of fiscal year 2014, including both current and long-term assets.
What are Umbra Companies's capital expenditures?
Umbra Companies (UCIX) invested $0 in capital expenditures during fiscal year 2014, funding long-term assets and infrastructure.
How many shares does Umbra Companies have outstanding?
Umbra Companies (UCIX) had 62M shares outstanding as of fiscal year 2014.
What is Umbra Companies's current ratio?
Umbra Companies (UCIX) had a current ratio of 0.00 as of fiscal year 2014, which is below 1.0, which may suggest potential liquidity concerns.
What is Umbra Companies's debt-to-equity ratio?
Umbra Companies (UCIX) had a debt-to-equity ratio of 0.17 as of fiscal year 2014, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Umbra Companies's return on assets (ROA)?
Umbra Companies (UCIX) had a return on assets of -33.7% for fiscal year 2014, measuring how efficiently the company uses its assets to generate profit.
What is Umbra Companies's cash runway?
Based on fiscal year 2014 data, Umbra Companies (UCIX) had -$7K in cash against an annual operating cash burn of $286K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Umbra Companies's Piotroski F-Score?
Umbra Companies (UCIX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Umbra Companies's earnings high quality?
Umbra Companies (UCIX) has an earnings quality ratio of 0.53x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Umbra Companies cover its interest payments?
Umbra Companies (UCIX) has an interest coverage ratio of -12.3x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.